AVEO Pharmaceuticals, Inc.
USD15.00
+0.00 (+0.00%)
CEO
Michael P. Bailey
IPO Date
2010-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.99
Prev. Close
$15.00
Day Low
$14.99
Day High
$15.00
52W Low
$3.07
52W High
$15.00
Volume
0.25M
| -3.5 |
| 31 Dec 2019 | FY | 100.0% | 32.6% | 63.2% | 18.6% | 1.06 | 2.40 | 10.2 |
| 31 Dec 2018 | FY | 100.0% | -98.5% | 19.6% | -19.1% | -0.70 | 1.54 | -39.3 |
| 31 Dec 2017 | FY | 100.0% | -858.0% | 159.5% | -129.5% | -0.91 | 1.56 | -4.5 |
| 31 Dec 2016 | FY | 100.0% | -1069.1% | 1398.2% | -98.5% | -7.28 | 2.54 | -1.4 |
| 31 Dec 2015 | FY | 100.0% | -78.9% | -87.1% | -37.0% | 0.55 | 3.26 | -4.7 |
| 31 Dec 2014 | FY | 100.0% | -291.0% | -255.9% | -74.6% | 1.00 | 1.47 | -0.8 |
| 31 Dec 2013 | FY | 100.0% | -8277.6% | -153.0% | -73.1% | 0.27 | 4.10 | -0.9 |
| 31 Dec 2012 | FY | 100.0% | -593.1% | -96.2% | -55.1% | 0.22 | 4.87 | -3.1 |
| -6.0 |
| 31 Mar 2022 | Q1 | 88.4% | -54.4% | -30.8% | -11.6% | 1.03 | 4.81 | -4.2 |
| 31 Dec 2021 | Q4 | 85.7% | -107.5% | -33.3% | -14.5% | 0.00 | 5.59 | -2.6 |
| 30 Sept 2021 | Q3 | 88.5% | -68.3% | -20.2% | -9.5% | 0.65 | 4.83 | -5.1 |
| 30 Jun 2021 | Q2 | 89.1% | -179.9% | -22.6% | -12.0% | 0.55 | 6.39 | -4.2 |
| 31 Mar 2021 | Q1 | 92.8% | -1152.2% | -30.5% | -17.4% | 0.46 | 6.38 | -2.3 |
| 31 Dec 2020 | Q4 | 100.0% | -1298.4% | -32.6% | -17.2% | 0.40 | 3.87 | -3.3 |
| 30 Sept 2020 | Q3 | 100.0% | -233.1% | -20.9% | -11.5% | 0.35 | 4.29 | -4.6 |
| 30 Jun 2020 | Q2 | 100.0% | -975.4% | -15.2% | -9.7% | 0.24 | 3.41 | -3.1 |